Clinical Trial: Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951854) titled 'Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder' on April 23.

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled, therapeutic exploratory Phase 2 clinical trial designed to evaluate the efficacy and safety of NV01-A02 in pediatric participants diagnosed with Autism Spectrum Disorder (ASD).

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Autism Spectrum Disorder (ASD

Intervention: DRUG: Drug: NV01-A02

NV01-A02 will be administered orally at a different dose once daily for 8 weeks. The formulation is a white, film-co...